Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Progressive or recurrent Intermediate or High risk, Non-muscle invasive bladder Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I